Prognomix
Çan, Canakkale, Turkey
About Prognomix
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $4.1M
- Last round: Series Unknown (Mar 2007)
- Website: prognomix.com
- Phone: 514-529-9757
Industries & Categories
Biotechnology, Genetics
Canonical: https://fsome.com/organization/prognomix-2472854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.